BLFS
Price
$23.29
Change
+$1.95 (+9.14%)
Updated
May 9 closing price
Capitalization
810.87M
87 days until earnings call
BWAY
Price
$8.71
Change
-$0.16 (-1.80%)
Updated
May 9 closing price
Capitalization
86.77M
One day until earnings call
Ad is loading...

BLFS vs BWAY

Header iconBLFS vs BWAY Comparison
Open Charts BLFS vs BWAYBanner chart's image
BioLife Solutions
Price$23.29
Change+$1.95 (+9.14%)
Volume$1.16M
Capitalization810.87M
BrainsWay
Price$8.71
Change-$0.16 (-1.80%)
Volume$12.44K
Capitalization86.77M
BLFS vs BWAY Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. BWAY commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and BWAY is a Hold.

Ad is loading...
COMPARISON
Comparison
May 12, 2025
Stock price -- (BLFS: $23.29 vs. BWAY: $8.71)
Brand notoriety: BLFS and BWAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 213% vs. BWAY: 32%
Market capitalization -- BLFS: $810.87M vs. BWAY: $86.77M
BLFS [@Medical Specialties] is valued at $810.87M. BWAY’s [@Medical Specialties] market capitalization is $86.77M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileBWAY’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • BWAY’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than BWAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 4 TA indicator(s) are bullish while BWAY’s TA Score has 4 bullish TA indicator(s).

  • BLFS’s TA Score: 4 bullish, 7 bearish.
  • BWAY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BWAY is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Medical Specialties) experienced а -7.84% price change this week, while BWAY (@Medical Specialties) price change was -3.44% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.49%. For the same industry, the average monthly price growth was +3.17%, and the average quarterly price growth was -3.96%.

Reported Earning Dates

BLFS is expected to report earnings on Aug 07, 2025.

BWAY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (-1.49% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($811M) has a higher market cap than BWAY($86.8M). BWAY YTD gains are higher at: -7.635 vs. BLFS (-10.285). BWAY has higher annual earnings (EBITDA): -8.43M vs. BLFS (-45.24M). BLFS has more cash in the bank: 51.7M vs. BWAY (44.2M). BWAY has less debt than BLFS: BWAY (754K) vs BLFS (42.7M). BLFS has higher revenues than BWAY: BLFS (143M) vs BWAY (28.8M).
BLFSBWAYBLFS / BWAY
Capitalization811M86.8M934%
EBITDA-45.24M-8.43M537%
Gain YTD-10.285-7.635135%
P/E Ratio238.10N/A-
Revenue143M28.8M497%
Total Cash51.7M44.2M117%
Total Debt42.7M754K5,663%
FUNDAMENTALS RATINGS
BLFS vs BWAY: Fundamental Ratings
BLFS
BWAY
OUTLOOK RATING
1..100
1111
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
7590
SMR RATING
1..100
9086
PRICE GROWTH RATING
1..100
5555
P/E GROWTH RATING
1..100
15100
SEASONALITY SCORE
1..100
9547

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BWAY's Valuation (73) in the Medical Specialties industry is in the same range as BLFS (95). This means that BWAY’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (75) in the Medical Specialties industry is in the same range as BWAY (90). This means that BLFS’s stock grew similarly to BWAY’s over the last 12 months.

BWAY's SMR Rating (86) in the Medical Specialties industry is in the same range as BLFS (90). This means that BWAY’s stock grew similarly to BLFS’s over the last 12 months.

BWAY's Price Growth Rating (55) in the Medical Specialties industry is in the same range as BLFS (55). This means that BWAY’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's P/E Growth Rating (15) in the Medical Specialties industry is significantly better than the same rating for BWAY (100). This means that BLFS’s stock grew significantly faster than BWAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSBWAY
RSI
ODDS (%)
Bullish Trend 5 days ago
64%
Bullish Trend 4 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 7 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
74%
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALYAF1.310.04
+3.15%
Alithya Group Inc.
UNCRY30.300.38
+1.27%
UniCredito Spa
SGBLY12.500.13
+1.05%
Standard Bank Group Ltd.
MZDAY2.960.01
+0.48%
Mazda Motor Corp.
FMCKJ11.36-0.04
-0.35%
Freddie Mac

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+9.14%
RGEN - BLFS
55%
Loosely correlated
-3.61%
DHR - BLFS
47%
Loosely correlated
-2.61%
GH - BLFS
46%
Loosely correlated
+0.10%
RVTY - BLFS
46%
Loosely correlated
-1.78%
QTRX - BLFS
45%
Loosely correlated
-4.17%
More

BWAY and

Correlation & Price change

A.I.dvisor tells us that BWAY and OFIX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BWAY and OFIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BWAY
1D Price
Change %
BWAY100%
-1.80%
OFIX - BWAY
33%
Poorly correlated
-1.62%
IRMD - BWAY
29%
Poorly correlated
-1.54%
BLFS - BWAY
29%
Poorly correlated
+9.14%
CLPT - BWAY
29%
Poorly correlated
-0.98%
BFLY - BWAY
28%
Poorly correlated
-1.76%
More